Gallagher Duncan - Insider Non-Derivative Transactions at Health Catalyst, Inc. (HCAT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 1, 2025, Gallagher Duncan's relationship to Health Catalyst, Inc. (HCAT) is Director, and currently has 124,461 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other HCAT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Gallagher Duncan - Insider Non-Derivative Transactions of HCAT Common Stock

Gallagher Duncan - Insider Non-Derivative Transactions at HCAT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 2, 2025	Acquisition -- (Common Stock)	6209	0	124461
Sep 2, 2025	Acquisition -- (Common Stock)	4970	0	118252
Jul 10, 2025	Acquisition -- (Common Stock)	36231	0	113282
Jun 2, 2025	Acquisition -- (Common Stock)	4080	0	77051
Mar 2, 2025	Acquisition -- (Common Stock)	3033	0	72971
Dec 31, 2024	Sell -- (Common Stock)	4500	6.93	69938
Dec 24, 2024	Sell -- (Common Stock)	4500	6.98	74438
Dec 2, 2024	Acquisition -- (Common Stock)	2001	0	78938
Sep 2, 2024	Acquisition -- (Common Stock)	2414	0	76937
Jun 14, 2024	Acquisition -- (Common Stock)	20807	0	74523
Jun 15, 2023	Acquisition -- (Common Stock)	5806	0	41211
Jun 15, 2023	Acquisition -- (Common Stock)	12505	0	53716